You need to enable JavaScript to run this app.
FDA official: Agency will not extend 2023 DSCSA interoperability deadline
Regulatory News
Joanne S. Eglovitch
North America
Pharmaceuticals
Regulatory NewsJoanne S. Eglovitch
North AmericaPharmaceuticalsRegulatory NewsJoanne S. EglovitchNorth AmericaPharmaceuticals